Search research articles
Contact Us
Filters
Showing results (61-70 of 266) with videos related to
Page
of 27
Sort By:
Oncoimmunology
|
April 28, 2022
Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis
Alberto Carretero-González, Marta Hergueta-Redondo, Sara Sánchez-Redondo, et al.
The Oncologist
|
September 23, 2022
Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy
Toni K Choueiri, Camillo Porta, Cristina Suárez, et al.
Cancer Metastasis Reviews
|
July 20, 2010
Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations
Emiliano Calvo, Pablo Maroto, Xavier García del Muro, et al.
Cancer Metastasis Reviews
|
July 20, 2010
Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma
Emiliano Calvo, Pablo Maroto, Xavier García del Muro, et al.
Atherosclerosis
|
May 19, 2019
Role of epicardial adipose tissue NPR-C in acute coronary syndrome
Inmaculada Moreno-Santos, Manuel Macías-González, Carlos Porras-Martín, et al.
Expert Opinion on Drug Safety
|
July 9, 2014
Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program
Daniel Castellano, Luis M Antón Aparicio, Emilio Esteban, et al.
Oncotarget
|
December 1, 2016
Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients
Xiaoyan Liu, Jesse J Swen, Epie Boven, et al.
Japanese Journal of Clinical Oncology
|
March 19, 2021
Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease
Hiroyoshi Suzuki, Daniel Castellano, Johann de Bono, et al.
Frontiers in Microbiology
|
October 21, 2017
Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus
Lidia Sanchez-Alcoholado, Daniel Castellano-Castillo, Laura Jordán-Martínez, et al.
Oncotarget
|
December 14, 2020
A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial
Guillermo de Velasco, Lucia Carril-Ajuria, Felix Guerrero-Ramos, et al.
Page
of 27
Search research articles
Search
Showing results (61-70 of 266) with videos related to
Sort By:
Page
of 27
Oncoimmunology
|
April 28, 2022
Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis
Alberto Carretero-González, Marta Hergueta-Redondo, Sara Sánchez-Redondo, et al.
The Oncologist
|
September 23, 2022
Randomized Phase II Trial of Sapanisertib ± TAK-117 vs. Everolimus in Patients With Advanced Renal Cell Carcinoma After VEGF-Targeted Therapy
Toni K Choueiri, Camillo Porta, Cristina Suárez, et al.
Cancer Metastasis Reviews
|
July 20, 2010
Update from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma: focus on special populations
Emiliano Calvo, Pablo Maroto, Xavier García del Muro, et al.
Cancer Metastasis Reviews
|
July 20, 2010
Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma
Emiliano Calvo, Pablo Maroto, Xavier García del Muro, et al.
Atherosclerosis
|
May 19, 2019
Role of epicardial adipose tissue NPR-C in acute coronary syndrome
Inmaculada Moreno-Santos, Manuel Macías-González, Carlos Porras-Martín, et al.
Expert Opinion on Drug Safety
|
July 9, 2014
Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program
Daniel Castellano, Luis M Antón Aparicio, Emilio Esteban, et al.
Oncotarget
|
December 1, 2016
Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients
Xiaoyan Liu, Jesse J Swen, Epie Boven, et al.
Japanese Journal of Clinical Oncology
|
March 19, 2021
Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease
Hiroyoshi Suzuki, Daniel Castellano, Johann de Bono, et al.
Frontiers in Microbiology
|
October 21, 2017
Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus
Lidia Sanchez-Alcoholado, Daniel Castellano-Castillo, Laura Jordán-Martínez, et al.
Oncotarget
|
December 14, 2020
A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial
Guillermo de Velasco, Lucia Carril-Ajuria, Felix Guerrero-Ramos, et al.
Page
of 27